A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

The curious minds at ColdFusion explore how a CRISPR breakthrough is allowing scientists to reverse certain types of blindness.

CRISPR-based gene editing holds great promise, but off-target effects remain a major concern, especially across diverse ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Crispr Therapeutics AG ( (CRSP) ) has risen by 10.96%. Read on to learn why.Elevate Your Investing Strategy: Take advantage ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on ...

The Byers Award recognizes outstanding research by faculty members in the middle of their careers. Martin Kampman’s honorary ...

Names including Kohls, Plug Power, and Mara Holdings round out the list of the market's top 10 most-shorted stocks.

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.